IndexIQ Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
IndexIQ Advisors's ALNY Position: Q1 2022 in Review
IndexIQ Advisors increased its Alnylam Pharmaceuticals (ALNY) stake by 22% in Q1 2022, buying an estimated $65.1K and bringing the position to 2,413 shares worth $394K. The position accounts for 0.01% of the portfolio, ranked #786.
IndexIQ Advisors first reported a position in ALNY in Q4 2021 and has held it in 2 quarters since. 443 funds tracked by Wall St. Rank hold ALNY as of Q1 2022.
- IndexIQ Advisors held 2,413 shares of Alnylam Pharmaceuticals worth $394K as of Q1 2022.
- IndexIQ Advisors bought 427 Alnylam Pharmaceuticals shares in Q1 2022, an estimated $65.1K.
- Alnylam Pharmaceuticals made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #786 holding.
- IndexIQ Advisors first reported a position in Alnylam Pharmaceuticals in Q4 2021 and has held it in 2 quarters since.
- 443 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2022.
Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.